HomeCompareNPONF vs JNJ

NPONF vs JNJ: Dividend Comparison 2026

NPONF yields 5.48% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPONF wins by $10343.64M in total portfolio value
10 years
NPONF
NPONF
● Live price
5.48%
Share price
$469.64
Annual div
$25.72
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10343.66M
Annual income
$9,993,097,805.95
Full NPONF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NPONF vs JNJ

📍 NPONF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPONFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPONF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPONF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPONF
Annual income on $10K today (after 15% tax)
$465.47/yr
After 10yr DRIP, annual income (after tax)
$8,494,133,135.06/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NPONF beats the other by $8,494,132,431.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPONF + JNJ for your $10,000?

NPONF: 50%JNJ: 50%
100% JNJ50/50100% NPONF
Portfolio after 10yr
$5171.84M
Annual income
$4,996,549,316.87/yr
Blended yield
96.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NPONF
No analyst data
Altman Z
1.3
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPONF buys
0
JNJ buys
0
No recent congressional trades found for NPONF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPONFJNJ
Forward yield5.48%3.36%
Annual dividend / share$25.72$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$10343.66M$20.0K
Annual income after 10y$9,993,097,805.95$827.78
Total dividends collected$10319.23M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NPONF vs JNJ ($10,000, DRIP)

YearNPONF PortfolioNPONF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,795$1,095.21$10,676$355.77+$1.1KNPONF
2$15,036$2,414.63$11,407$389.39+$3.6KNPONF
3$21,841$5,753.21$12,198$426.53+$9.6KNPONF
4$38,991$15,621.21$13,056$467.62+$25.9KNPONF
5$93,846$52,125.70$13,987$513.12+$79.9KNPONF
6$334,918$234,502.77$14,998$563.56+$319.9KNPONF
7$1,922,647$1,564,284.11$16,098$619.52+$1.91MNPONF
8$18,842,271$16,785,038.70$17,295$681.69+$18.82MNPONF
9$327,630,909$307,469,678.99$18,599$750.82+$327.61MNPONF
10$10,343,662,878$9,993,097,805.95$20,022$827.78+$10343.64MNPONF

NPONF vs JNJ: Complete Analysis 2026

NPONFStock

NPR was established on Nov. 7, 2012, based on the Act on Investment Trust and Investment Corporation (investment trust law) and was listed on the REIT Securities Market (J-REIT Market) of the Tokyo Stock Exchange ("TSE") on Feb. 14, 2013 (securities code: 3283).

Full NPONF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NPONF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPONF vs SCHDNPONF vs JEPINPONF vs ONPONF vs KONPONF vs MAINNPONF vs ABBVNPONF vs MRKNPONF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.